Cyrus J. Lawrence’s AbbVie ABBV Stock Holding History

Cyrus J. Lawrence’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-959	Closed	-$170K	–	43
2024 Q4	$170K	Sell	959 -150	-14%	-$27.6K	0.03%	75
2024 Q3	$219K	Sell	1,109 -5	-0.4%	-$933	0.04%	67
2024 Q2	$191K	Hold	1,114	–	–	0.04%	68
2024 Q1	$202K	Buy	+1,114	New	+$192K	0.04%	69
2023 Q3	$176K	Hold	1,182	–	–	0.05%	67
2023 Q2	$159K	Sell	1,182 -10	-0.8%	-$1.47K	0.03%	68
2023 Q1	$190K	Sell	1,192 -525	-31%	-$80.3K	0.06%	67
2022 Q4	$277K	Buy	+1,717	New	+$263K	0.08%	62
2022 Q3	–	Sell	-2,444	Closed	-$374K	–	188
2022 Q2	$374K	Hold	2,444	–	–	0.11%	65
2022 Q1	$396K	Buy	+2,444	New	+$355K	0.09%	68

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Cyrus J. Lawrence's ABBV Position: Q1 2025 in Review

Cyrus J. Lawrence sold out of AbbVie (ABBV) in Q1 2025, closing a stake of 959 shares — an estimated $170K sold.

Cyrus J. Lawrence first reported a position in ABBV in Q1 2022 and held it in 10 quarters. The position peaked at $396K in Q1 2022. 3,826 funds tracked by Wall St. Rank hold ABBV as of Q1 2025.

Cyrus J. Lawrence reported no remaining AbbVie position as of Q1 2025 after selling out during the quarter.
Cyrus J. Lawrence sold 959 AbbVie shares in Q1 2025, an estimated $170K.
Cyrus J. Lawrence first reported a position in AbbVie in Q1 2022 and held it in 10 quarters.
Cyrus J. Lawrence's AbbVie position peaked at $396K in Q1 2022.
3,826 funds tracked by Wall St. Rank held AbbVie as of Q1 2025.

Based on Cyrus J. Lawrence's 13F filing for Q1 2025, filed 15 May 2025.